Newer studies have found that purely somatic mutations in the FH gene may also lead to FH-deficient RCC, and that these patients without germline mutations will not exhibit the other symptomatic manifestations of HLRCC, and that specific FH mutations do not appear to alter the aggressive behavior and poor prognosis associated with this tumor (4). The gene discussed is FH; the disease is neoplasm.